Author: Addition Therapeutics, Inc

Addition Therapeutics to Present Preclinical Data from PRINT™ Programs at the European Society of Gene & Cell Therapy’s (ESGCT) 33rd Annual Congress

October 27, 2026
Addition Therapeutics Presents Preclinical Proof-of-Concept Data at American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting

May 12, 2026

Addition Therapeutics to Present Preclinical Data from PRINT™ Programs at the European Society of Gene & Cell Therapy’s (ESGCT) 33rd Annual Congress